Effects of hemodialysis and long-term erythropoietin treatment on protein C, and on free and total protein S.
We studied 37 hemodialysis patients during hemodialysis in order to assess the effects of dialysis on endogenous plasma coagulation inhibitors (antithrombin III, protein C, free and total protein S). The patients were examined prior to erythropoietin (EPO) treatment, upon reaching target hemoglobin (Hb) and after 3 months at steady state Hb levels. The levels of protein C increased significantly during dialysis. However, EPO treatment did not affect the levels of any of the endogenous coagulation inhibitors, either upon reaching target Hb or after 3 months of steady state Hb. The sequence of change during dialysis of protein C, free and total protein S was constant when comparing respective patterns prior to EPO treatment to those at target Hb and steady state Hb respectively. In conclusion, hemodialysis seems to activate synthesis of endogenous coagulation while partial correction of anaemia with EPO does not affect the levels of these inhibitors.
Clyne
N
N
Department of Internal Medicine, Karolinska Hospital, Stockholm, Sweden.
Egberg
N
N
Lins
L E
LE
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000704:Analysis of Variance; D000925:Anticoagulants / Q000494:pharmacology; D000990:Antithrombin III / Q000187:drug effects / Q000378:metabolism*; D001772:Blood Cell Count; D001777:Blood Coagulation / Q000187:drug effects*; D004921:Erythropoietin / Q000627:therapeutic use*; D005260:Female; D006454:Hemoglobins / Q000187:drug effects; D006493:Heparin / Q000494:pharmacology; D006801:Humans; D008297:Male; D008875:Middle Aged; D011486:Protein C / Q000187:drug effects / Q000378:metabolism*; D017293:Protein S / Q000187:drug effects / Q000378:metabolism*; D006435:Renal Dialysis; D014511:Uremia / Q000097:blood / Q000628:therapy
D000925:Anticoagulants; D006454:Hemoglobins; D011486:Protein C; D017293:Protein S; D004921:Erythropoietin; D000990:Antithrombin III; D006493:Heparin